{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:34:08Z","timestamp":1772728448472,"version":"3.50.1"},"reference-count":11,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T00:00:00Z","timestamp":1230076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:p>Gout and pain are synonymous, and a study in this issue of the <jats:italic>BJP<\/jats:italic> reports a novel anti\u2010nociceptive effect of allopurinol, the drug most commonly used to treat gout. Allopurinol works by inhibiting xanthine oxidase (XO), the enzyme responsible for converting hypoxanthine to uric acid which is deposited as crystals in the joints of gout sufferers. Hypoxanthine is a metabolite of, and a possible precursor to, adenosine. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b8\">Schmidt <jats:italic>et\u2003al.<\/jats:italic><\/jats:ext-link>, find that acute inhibition of XO with allopurinol produces a modest adenosine A<jats:sub>1<\/jats:sub> receptor\u2010mediated anti\u2010nociceptive effect in common tests of chemical and thermal nociception in mice. A concomitant increase in cerebrospinal fluid levels of adenosine supports their hypothesis that inhibiting XO increases adenosine levels via salvage from hypoxanthine. Elevating endogenous adenosine levels by inhibiting metabolism is a well\u2010established strategy for producing anti\u2010nociception in many preclinical models, but inhibiting XO is likely to be particularly beneficial in some chronic pain states because of the pro\u2010nociceptive reactive oxygen species that are produced by XO activity. Thus, allopurinol may have unexpected benefits in pain associated with chronic inflammation, diabetes and vascular dysfunction.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2008.00065.x","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T23:53:08Z","timestamp":1234482788000},"page":"4-6","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Allopurinol for pain relief: more than just crystal clearance?"],"prefix":"10.1111","volume":"156","author":[{"given":"Mark","family":"Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,24]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02788381","article-title":"Does allopurinol reduce the pain of chronic pancreatitis","volume":"22","author":"Banks PA","year":"1997","journal-title":"Int J Pancreatol"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H121"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(63)90012-1"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.12.029"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00435-3"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.1.6"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1991.01410330067010"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(03)00050-9"},{"key":"e_1_2_5_10_1","first-page":"161","article-title":"Antinociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of adenosine A1 receptors","volume":"156","author":"Schmidt AP","year":"2008","journal-title":"Br J Pharmacol"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2004.10.031"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2007.04639.x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2008.00065.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2008.00065.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:18:39Z","timestamp":1697404719000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2008.00065.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,24]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1476-5381.2008.00065.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00065.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,24]]},"assertion":[{"value":"2008-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}